1021 related articles for article (PubMed ID: 19302064)
1. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
2. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
4. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
Holness MJ; Priestman DA; Sugden MC
J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
[TBL] [Abstract][Full Text] [Related]
5. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
[TBL] [Abstract][Full Text] [Related]
7. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
8. Effects of proglycosyn (LY177507) on fatty acid metabolism in rat hepatocytes.
Guzmán M; Geelen MJ; Harris RA
Arch Biochem Biophys; 1993 Aug; 305(1):141-6. PubMed ID: 8102045
[TBL] [Abstract][Full Text] [Related]
9. Hormonal control of fatty acid oxidation during the neonatal period.
Pegorier JP; Prip-Buus C; Duee PH; Girard J
Diabete Metab; 1992; 18(1 Pt 2):156-60. PubMed ID: 1563551
[TBL] [Abstract][Full Text] [Related]
10. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
[TBL] [Abstract][Full Text] [Related]
12. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity.
Faye A; Borthwick K; Esnous C; Price NT; Gobin S; Jackson VN; Zammit VA; Girard J; Prip-Buus C
Biochem J; 2005 Apr; 387(Pt 1):67-76. PubMed ID: 15498023
[TBL] [Abstract][Full Text] [Related]
14. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes.
Prip-Buus C; Pegorier JP; Duee PH; Kohl C; Girard J
Biochem J; 1990 Jul; 269(2):409-15. PubMed ID: 2167069
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
17. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
Sebastián D; Herrero L; Serra D; Asins G; Hegardt FG
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E677-86. PubMed ID: 17062841
[TBL] [Abstract][Full Text] [Related]
18. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
19. Rapid switch of hepatic fatty acid metabolism from oxidation to esterification during diurnal feeding of meal-fed rats correlates with changes in the properties of acetyl-CoA carboxylase, but not of carnitine palmitoyltransferase I.
Moir AM; Zammit VA
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):241-6. PubMed ID: 8097087
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.
Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
